Monoclonal antibody-based assay for Alt a1, a major Alternaria allergen

Ann Allergy Asthma Immunol. 1998 Jul;81(1):59-64. doi: 10.1016/s1081-1206(10)63110-9.

Abstract

Background: Allergenic materials from Alternaria are significant causes of human disease. One 31-kD glycoprotein, designated Alt a1, has been described previously as being a significant allergen.

Objectives: The purpose of this study is to characterize purified Alt a1 and to provide a method for measuring it in laboratory and environmental samples.

Methods: Monoclonal antibodies directed to the purified allergen were produced and used to construct a double monoclonal assay for Alt a1. The purified allergen detected by this assay was tested for IgE binding in vitro and in vivo.

Results: Purified allergen detected by this assay was shown to bind IgE from patients sensitive to Alternaria and gave a positive skin test in 15 of 16 patients skin test reactive to commercial Alternaria extracts. The assay is sensitive to Alt a1 concentrations as low as 0.2 microg/nmL and is very specific for the allergen. The three commercial Alternaria extracts assayed contained measurable quantities of the allergen varying from 12 to 84 microg/mL.

Conclusions: Alt a1 is a significant Alternaria allergen. The ability to measure this allergen may assist in standardizing Alternaria extracts and lead to an understanding of the significance of exposure to this allergen.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Allergens / analysis*
  • Alternaria / immunology*
  • Animals
  • Antibodies, Monoclonal / immunology*
  • Humans
  • Immunoblotting
  • Immunoglobulin E / immunology
  • Mice
  • Mice, Inbred BALB C
  • Skin Tests

Substances

  • Allergens
  • Antibodies, Monoclonal
  • Immunoglobulin E